Table 1.

Eight hits from 1280 pharmacologically active compounds were found to disrupt the formation of the K292Q‐Hsp90/S13D‐Cdc37 complex in MDA‐MB‐231 cells

Inhibition (%)	Compound (10 μmol/L)
54	Bosutinib
97	Cisplatin
92	Simvastatin
80	Carmofur
58	Nisoldipine
61	Mevastatin
89	Phenoxybenzamine HCl
54	Rolitetracycline